Biotech: time to stop blocking women leaders
This article was originally published in Scrip
The recent Liftstream report on gender diversity in biotech made for interesting reading. Although women make up the majority of the workforce entering biopharma, and account for more than half of graduates with a life science PhD, their presence in the boardrooms and senior leadership teams of small and medium-sized biotech firms is paltry.
You may also be interested in...
See how much the CEOs and R&D heads of the world’s biggest pharma companies get paid, and how those companies are performing.
Merck & Co is gradually catching up with Roche in PD-1/L1 first-line triple-negative breast cancer treatment, but its presentation at ASCO on Keynote-355 includes mixed PFS results. Overall survival data will be key to Keytruda’s competitiveness.
INFOGRAPHIC: A snapshot of the compensation packages granted to the chiefs of the world’s biggest pharma companies, along with key performance stats for the businesses they lead.